Chris Bonnett, PhD, provides practical health policy research primarily for public and private drug plan leaders, and advises on strategies to improve health in the workplace. His 2020 doctorate focused on social insurance as a way to achieve universal drug insurance. He has made submissions to Health Canada, The House of Commons Standing Committee on Health, the Advisory Council on the Implementation of National Pharmacare, and CADTH (rare disease drug formulary). He established H3 Consulting after 18 years of progressive experience in employee benefits.